Amgen will employ the Veeva Clinical Platform to support and identify efficiencies across the clinical trial process. "We're excited to help Amgen further advance clinical development. Veeva Clinical ...
With a commitment to process optimization, training, and audits to enhance their operations, CROs can ensure the integrity of medications throughout the trial process. The Fast Company Executive Board ...
The clinical trial process is broken for a variety of reasons, ranging from the difficulty of designing trial protocols to the cost of running them. But one critical (and solvable) issue is finding, ...
Two of the biggest problems for clinical trials are old ones: recruiting patients to participate and keeping them in a trial for the duration of the study. New technologies can help. By making the ...
Many people are surprised to learn that clinical trials aren't just for people who have run out of standard treatment options ...
World-leading challenge study expertise helping deliver scalable, high-quality outpatient vaccine trials in healthy ...
Flow cytometry has become a key analytical technique in clinical trials. Through its multiparametric analysis, single-cell resolution, and high-throughput evaluation capabilities, flow cytometry can ...
Generative Artificial Intelligence (Gen AI) can rapidly and accurately screen patients for clinical trial eligibility, according to a new study from Mass General Brigham researchers. Such technology ...
This analysis is by Bloomberg Intelligence Industry Analyst Andrew Galler and Senior Associate Analyst Jack Maltby. It appeared first on the Bloomberg Terminal. Clinical trials represent a significant ...
Our Care Advisors will connect you with the best healthcare provider for your needs. MSK is a leader in cancer clinical trials. We often have many trials at a time, researching different types of ...
Navigating a cancer diagnosis can be overwhelming, from managing a surge of unfamiliar emotions to weighing complex treatment decisions. Many patients are aware of clinical trials, yet uncertainty ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results